These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35470761)

  • 1. A critical assessment of the current pharmacotherapy for the treatment of embolic strokes of undetermined source.
    Lattanzi S; Acampa M; Norata D; Broggi S; Caso V
    Expert Opin Pharmacother; 2022 Jun; 23(8):905-915. PubMed ID: 35470761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-Case Report of Embolic Stroke of Undetermined Source.
    Li J; Yang XZ; Wang YP; Chen XL; Zhang X
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):e133-e137. PubMed ID: 28476509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reexamination of the Embolic Stroke of Undetermined Source Concept.
    Albers GW; Bernstein R; Brachmann J; Camm AJ; Fromm P; Goto S; Granger CB; Hohnloser SH; Hylek E; Krieger D; Passman R; Pines JM; Kowey P
    Stroke; 2021 Aug; 52(8):2715-2722. PubMed ID: 34192898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of Finding Embolic Sources for Patients with Embolic Stroke of Undetermined Source.
    Umemura T; Nishizawa S; Nakano Y; Saito T; Kitagawa T; Miyaoka R; Suzuki K; Yamamoto J
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1810-1815. PubMed ID: 31097326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.
    Kasner SE; Lavados P; Sharma M; Wang Y; Wang Y; Dávalos A; Shamalov N; Cunha L; Lindgren A; Mikulik R; Arauz A; Lang W; Czlonkowska A; Eckstein J; Gagliardi R; Amarenco P; Ameriso SF; Tatlisumak T; Veltkamp R; Hankey GJ; Toni DS; Bereczki D; Uchiyama S; Ntaios G; Yoon BW; Brouns R; DeVries Basson MM; Endres M; Muir K; Bornstein N; Ozturk S; O'Donnell M; Mundl H; Pater C; Weitz J; Peacock WF; Swaminathan B; Kirsch B; Berkowitz SD; Peters G; Pare G; Themeles E; Shoamanesh A; Connolly SJ; Hart RG;
    J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1673-1682. PubMed ID: 29525076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Embolic Stroke of Undetermined Source: JACC Review Topic of the Week.
    Ntaios G
    J Am Coll Cardiol; 2020 Jan; 75(3):333-340. PubMed ID: 31976872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Review and update of the concept of embolic stroke of undetermined source.
    Diener HC; Easton JD; Hart RG; Kasner S; Kamel H; Ntaios G
    Nat Rev Neurol; 2022 Aug; 18(8):455-465. PubMed ID: 35538232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.
    Hart RG; Veltkamp RC; Sheridan P; Sharma M; Kasner SE; Bangdiwala SI; Ntaios G; Shoamanesh A; Ameriso SF; Toni D; Czlonkowska A; Lindgren A; Hankey GJ; Perera KS; Shuaib A; Coutts SB; Gagliardi RJ; Berkowitz SD; Mundl H; Peters G; Connolly SJ;
    J Stroke Cerebrovasc Dis; 2019 Aug; 28(8):2273-2279. PubMed ID: 31160218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supracardiac atherosclerosis in embolic stroke of undetermined source: the underestimated source.
    Ntaios G; Wintermark M; Michel P
    Eur Heart J; 2021 May; 42(18):1789-1796. PubMed ID: 32300781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source: Secondary Analysis of a Randomized Clinical Trial.
    Veltkamp R; Pearce LA; Korompoki E; Sharma M; Kasner SE; Toni D; Ameriso SF; Mundl H; Tatlisumak T; Hankey GJ; Lindgren A; Berkowitz SD; Arauz A; Ozturk S; Muir KW; Chamorro Á; Perera K; Shuaib A; Rudilosso S; Shoamanesh A; Connolly SJ; Hart RG
    JAMA Neurol; 2020 Oct; 77(10):1233-1240. PubMed ID: 32628266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embolic infarct topology differs between atrial fibrillation subtypes and embolic stroke of undetermined source.
    Wolfe J; Oak S; Tiongson J; Vigilante N; Frost E; Penckofer M; Thau L; Iezzi Z; Patel P; Siegler JE
    J Stroke Cerebrovasc Dis; 2022 Nov; 31(11):106782. PubMed ID: 36130470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embolic Stroke of Undetermined Source: Gateway to a New Stroke Entity?
    Schäbitz WR; Köhrmann M; Schellinger PD; Minnerup J; Fisher M
    Am J Med; 2020 Jul; 133(7):795-801. PubMed ID: 32247819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary Stroke Prevention in Cryptogenic Stroke and Embolic Stroke of Undetermined Source (ESUS).
    Diener HC; Bernstein R; Hart R
    Curr Neurol Neurosci Rep; 2017 Sep; 17(9):64. PubMed ID: 28707135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ESUS (embolic stroke of undetermined sources)].
    Kitagawa K
    Nihon Rinsho; 2016 Apr; 74(4):597-602. PubMed ID: 27333746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Embolic Sources and Outcomes in Embolic Stroke of Undetermined Source in the NAVIGATE-ESUS Trial.
    Ntaios G; Pearce LA; Veltkamp R; Sharma M; Kasner SE; Korompoki E; Milionis H; Mundl H; Berkowitz SD; Connolly SJ; Hart RG;
    Stroke; 2020 Jun; 51(6):1797-1804. PubMed ID: 32295509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.
    Diener HC; Sacco RL; Easton JD; Granger CB; Bar M; Bernstein RA; Brainin M; Brueckmann M; Cronin L; Donnan G; Gdovinová Z; Grauer C; Kleine E; Kleinig TJ; Lyrer P; Martins S; Meyerhoff J; Milling T; Pfeilschifter W; Poli S; Reif M; Rose DZ; Šaňák D; Schäbitz WR
    Stroke; 2020 Jun; 51(6):1758-1765. PubMed ID: 32404035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of Randomized, double-blind, Evaluation in secondary Stroke Prevention comparing the EfficaCy and safety of the oral Thrombin inhibitor dabigatran etexilate vs. acetylsalicylic acid in patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS).
    Diener HC; Easton JD; Granger CB; Cronin L; Duffy C; Cotton D; Brueckmann M; Sacco RL;
    Int J Stroke; 2015 Dec; 10(8):1309-12. PubMed ID: 26420134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non vitamin K oral anticoagulants versus antiplatelets in embolic stroke of undetermined source: most updated evidence.
    Chatterjee S; Dubey S; Lahiri D; Ray BK
    Minerva Cardioangiol; 2019 Aug; 67(4):340-347. PubMed ID: 31220915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial: Recurrent stroke risk and response to antithrombotic therapy.
    Ameriso SF; Amarenco P; Pearce LA; Perera KS; Ntaios G; Lang W; Bereczki D; Uchiyama S; Kasner SE; Yoon BW; Lavados P; Firstenfeld A; Mikulik R; Povedano GP; Ferrari J; Mundl H; Berkowitz SD; Connolly SJ; Hart RG
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104936. PubMed ID: 32689594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embolic Stroke of Undetermined Source: Current Perspectives on Diagnosis, Investigations, and Management.
    Field TS; Sposato LA; Hill MD; Healey JS; Andrade JG; Zhou LW
    Can J Cardiol; 2023 Feb; 39(2):172-186. PubMed ID: 36272633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.